Skip to main content

Exxon’s $59.5 billion deal for Pioneer Natural Resources tops 2023 deals in moribund M&A market

Exxon's all-stock acquisition of Permian Basin oil and gas specialist beats out Pfizer's $44.6 billion acquisition of Seagen in a weak year for deals thus far.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.